Depreciation, Depletion and Amortization in USD of Orchard Therapeutics plc from 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Orchard Therapeutics plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2020 to Q1 2023.
  • Orchard Therapeutics plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $643K, a 9.31% decline year-over-year.
  • Orchard Therapeutics plc annual Depreciation, Depletion and Amortization for 2022 was $2.74M, a 17.8% increase from 2021.
  • Orchard Therapeutics plc annual Depreciation, Depletion and Amortization for 2021 was $2.33M, a 16.1% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)

Orchard Therapeutics plc Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $643K -$66K -9.31% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $709K +$214K +43.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $495K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Orchard Therapeutics plc Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.74M +$414K +17.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $2.33M +$323K +16.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.